Skip to content

The Effects of Morning vs. Evening Mindfulness Meditation on Sleep, Anxiety, and Decentering: A Pilot Analysis

Thomas Basala, Brigitte Morin, John Durocher

The FASEB Journal May 1, 2022 DOI: 10.1096/fasebj.2022.36.s1.l7631 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 16
Population College students
Dose 24-minute session
Duration 4-day baseline period followed by a 4-day intervention period
Measures Actiwatch Spectrum PRO (total sleep time, sleep efficiency), State-Trait Anxiety Inventory (STAI), Five Facet Mindfulness Questionnaire, Decentering Questionnaire
Topics Anxiety Meditation
Key findings A 24-minute mindfulness meditation practice over four days did not significantly change total sleep time or sleep efficiency in either morning or evening meditators, but significantly reduced state and trait anxiety and significantly increased the five facets of mindfulness and decentering, regardless of timing. The authors suggest acute meditation can improve several measures of psychological well-being whether practiced in the morning or evening.

Abstract

According to the CDC, most children and about 1 in 3 adults in the United States fail to reach their age group recommended quantity of sleep. Recently, non‐pharmacological sleep aids, such as meditation, have gained popularity. However, to our knowledge there is no research data that compares sleep metrics or psychological well‐being between those that meditate in the morning vs. in the evening. This study aims to investigate the potential circadian‐dependent effects of meditation timing and how it may influence metrics of sleep and psychological well‐being. We hypothesized that those who meditate just before sleep would have improved sleep parameters and self‐reported feelings of psychological well‐being when compared to those that meditate in the morning. Sixteen college students participated in the study, eight who meditated in the morning (5M; 3F) after waking and eight who meditated in the evening (4M; 4F) just before going to sleep. Participants were asked to wear an Actiwatch Spectrum PRO to evaluate physical activity and sleep throughout the recording periods. The first phase of the protocol consisted of a 4‐day (Monday‐Thursday) baseline recording period where total sleep time (TST) and sleep efficiency measures were recorded. Participants were instructed to not meditate during the baseline period. During the 4‐day intervention period which occurred the following week (Monday‐Thursday), participants were randomized to a 24‐minute pre‐sleep or morning mindfulness meditation intervention from the app Insight Timer . At the conclusion of both baseline and intervention time periods (on Friday of each respective week), participants were instructed to complete a state‐trait anxiety inventory (STAI), a Five Facts of Mindfulness Questionnaire, and a Decentering Questionnaire. Means were considered to be significantly different when p<0.05. The acute meditation protocols did not significantly change TST from baseline in the morning (6.7±0.2 vs. 6.8±0.2 hours) or evening (6.9±0.3 vs. 7.2±0.2 hours) meditators. Likewise, sleep efficiency was not significantly changed in either group. However, there was a significant decrease in both state and trait anxiety (baseline vs. treatment, p<0.02 for both), and a significant increase in the five facets of mindfulness and ability to decenter (baseline vs. treatment, p<0.01 for both). Our preliminary results suggest that acute meditation can help to improve several measures of psychological well‐being whether it is done in the morning or evening. Further investigation within our own study and from others may help to better understand whether evening meditation can offer specific sleep benefits.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Explore topics